Journal of Urologic Oncology

Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: Joongwon Choi, Tae Jin Kim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Minyong Kang, Seong Il Seo; Korean J Urol Oncol. 2019;17(3):150-159. Published online December 27, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.3.150; Full text PubReader ePub PDF Supplementary Material

Comparison of Synchronous and Metachronous Primary Carcinomas of the Bladder and Prostate: Ho Seok Chung, Young Ho Seo, Seung Il Jung, Eu Chang Hwang, Taek Won Kang, Dong Deuk Kwon; Korean J Urol Oncol. 2017;15(1):44-50. Published online April 26, 2017; DOI: https://doi.org/10.22465/kjuo.2017.15.1.44; Full text PubReader ePub PDF

Aggressive Variant of Chromophobe Renal Cell Carcinoma Accompanied by Tonsillar Squamous Cell Carcinoma: Min Chul Cho , Chang Ahn , Ji Hyeon Roh , Jungbum Bae , Jong Sun Choi , Eo-Jin Kim , Hae Won Lee , Kwang Soo Lee; Korean J Urol Oncol. 2013;11(2):94-97. Published online August 30, 2013; PDF

Incidentally Detected Adrenal Pheochromocytoma and Renal Cell Carcinoma of the Same Affected Side: Hae Won Lee , Hyoung Keun Park , Kwang Soo Lee; Korean J Urol Oncol. 2009;7(3):141-144. Published online December 1, 2009; PDF

Bilateral Renal Cell Carcinoma Detected Synchronously in Laryngeal Cancer: Woo Jin Kim , Jea Hoon Choi , Heung Ky Chung , Jea Hoon Chung , Sung Cheol Kam , Jeong Seok Hwa , Ky Hyun Chung; Korean J Urol Oncol. 2004;2(1):47-50. Published online March 30, 2004; PDF

7,852	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
6,588	Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
6,585	Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
5,808	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
5,701	Determinant of Aggressive Phenotype in Metastatic Hormone-Sensitive Prostate Cancer Depends on an Intrinsic, Highly Aggressive Cell Cluster: Integrated Single-Cell RNA and Whole Transcriptomic Sequencing Analyses

Cited By 9	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 7	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 7	Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By 4	Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Cited By 4	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians

Search